Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

DONNAGEL LIQ 6 G / 30 ML

KAOLIN : 6 G / 30 ML SCOPOLAMINE HYDROBROMIDE : 6.5 MCG / 30 ML ATROPINE SULFATE : 0.0194 MG / 30 ML HYOSCYAMINE SULFATE : 0.1037 MG / 30 ML PECTIN : 142.8 MG / 30 ML · DIN 01908006 · AYERST LABORATORIES

Health Canada status: CANCELLED POST MARKET

What is DONNAGEL LIQ?

DONNAGEL LIQ 6 G / 30 ML contains KAOLIN : 6 G / 30 ML SCOPOLAMINE HYDROBROMIDE : 6.5 MCG / 30 ML ATROPINE SULFATE : 0.0194 MG / 30 ML HYOSCYAMINE SULFATE : 0.1037 MG / 30 ML PECTIN : 142.8 MG / 30 ML. It is listed in the Health Canada Drug Product Database under DIN 01908006, held by AYERST LABORATORIES, supplied as LIQUID for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 10-Sep-1996. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN01908006
Brand nameDONNAGEL LIQ
Generic / active ingredientKAOLIN : 6 G / 30 ML SCOPOLAMINE HYDROBROMIDE : 6.5 MCG / 30 ML ATROPINE SULFATE : 0.0194 MG / 30 ML HYOSCYAMINE SULFATE : 0.1037 MG / 30 ML PECTIN : 142.8 MG / 30 ML
ManufacturerAYERST LABORATORIES
Strength6 G / 30 ML
Dosage formLIQUID
Route of administrationORAL
ScheduleEthical
ATC codeA07BC52 KAOLIN, COMBINATIONS
AHFS class56:08.00 ; 12:08.08
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date10-Sep-1996
Original market date1993-12-31 00:00:00

What can be used instead?

Other Canadian products sharing ATC code A07BC52 KAOLIN, COMBINATIONS. 0 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
DONNAGEL LIQ6 G / 30 MLLIQUIDWYETH-AYERST CANADA INC.CANCELLED POST MARKETDIN 02041774

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for DONNAGEL LIQ

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for DONNAGEL LIQ

Health Canada Drug Product Database (DPD), DIN 01908006. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.